Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$6.70
0.071.06%
Pre-Market: Mar 19, 4:33 PM EDT
Comments
Loading...
Atara Biotherapeutics Stock Price, Quotes and Forecasts
ATRANASDAQ
Atara Biotherapeutics (ATRA) Forecast
NewsEarningsAtara Biotherapeutics (ATRA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Atara Biotherapeutics Stock Price, Quotes and Forecasts | NASDAQ:ATRA | Benzinga
Explore Atara Biotherapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ATRA.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Atara Biotherapeutics (ATRA) stock?
You can purchase shares of Atara Biotherapeutics (NASDAQ:ATRA) through any online brokerage.
Who are Atara Biotherapeutics (ATRA) competitors?
Other companies in Atara Biotherapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), bluebird bio (NASDAQ:BLUE), Barinthus Biotherapeutics (NASDAQ:BRNS), OS Therapies (AMEX:OSTX) and CollPlant Biotechnologies (NASDAQ:CLGN).
What is the forecast, or price target, for Atara Biotherapeutics (ATRA) stock?
Atara Biotherapeutics has a consensus price target of $15.15.
What is the current price for Atara Biotherapeutics (ATRA)?
The stock price for Atara Biotherapeutics (NASDAQ: ATRA) is $6.7 last updated March 19, 2025 at 4:33 PM EDT.
Does Atara Biotherapeutics (ATRA) pay a dividend?
There are no upcoming dividends for Atara Biotherapeutics.
When is Atara Biotherapeutics (NASDAQ:ATRA) reporting earnings?
Atara Biotherapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
Is Atara Biotherapeutics (ATRA) going to split?
There is no upcoming split for Atara Biotherapeutics.
What sector and industry does Atara Biotherapeutics (ATRA) operate in?
Atara Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.